Pharmacotherapy, pharmacogenetics and pharmaceutical technology
PRINCIPAL INVESTIGATORS
- Pedro Alía Ramos
- Helena Colom Codina
- Josep Manel Llop Talaveron
- Beatriz Candás Estébanez
- Elisabet Leiva Badosa
CLINICAL RESEARCHERS
- María Bella Badia Tahull
- Josep Maria Suñe Negre
- Núria Llecha Cano
- Montserrat Miñarro Carmona
- Roser Juvany Roig
- Josep Ramon Tico Grau
- Ariadna Padró I Miquel
- Maria Pilar Pérez Lozano
- Encarna Garcia Montoya
- Ariadna Padullés Zamora
- Eugènia Santacana Juncosa
- Marc Suñé Pou
PREDOCTORAL RESEARCHERS
- Montserrat Colls Gonzalez
- Leticia Garrido Sanchez
- Javier Martínez Casanova
- Sara Cobo Sacristán
- Lorena Santulario Verdú
- Ana Suarez-Lledo Grande
MANAGEMENT SUPPORT
- Ana Maria Ferrer Artola
- Laura Canals Vilaseca
Translational Medicine
Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention
Scientific production
36
PAPERS
Average IF: 7,684
26
LED PAPERS
Average IF: 8,125
3 PUBLICATIONS IN FIRST DECILE
21 PUBLICATIONS IN FIRST QUARTILE
32 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Talaveron,JLM;Grande,A;Badosa,EL;Minguet,JB;Marti,JC;Canton,EP;Tahull,MBB, Inflammatory processes involved in the alteration of liver function biomarkers in adult hospitalized patients treated with parenteral nutrition, Front. Nutr., 2023;101034481-1034481, doi:10.3389/fnut.2023.1034481
- Rouaz Hajoui,K;García Montoya,E;López Urbano,A;Romero Obon,M;Chiclana Rodríguez,B;Fraschi Nieto,A;Nardi Ricart,A et al, Optimisation of the Manufacturing Process of Organic-Solvent-Free Omeprazole Enteric Pellets for the Paediatric Population: Full Factorial Design, Pharmaceutics, 2023;15(11):doi:10.3390/pharmaceutics15112587
- Ronda,M;Padulles,A;Grau,I;Tubau,F;Satorra,P;Shaw,E;Vigues,F et al, Impact of a prospective audit and feedback antimicrobial stewardship programme on carbapenem consumption: a quasi-experimental study (IPANEMA study), J. Antimicrob. Chemother., 2023;78(7):1705-1710, doi:10.1093/jac/dkad160
- Martinez Casanova,J;Esteve Pitarch,E;Colom Codina,H;Gumucio Sanguino,VD;Cobo Sacristan,S;Shaw,E;Maisterra Santos,K et al, Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients, Antibiotics-Basel, 2023;12(3):doi:10.3390/antibiotics12030531
- Gonzalez,CGR;de Vega,EC;Martinez,SD;Minero,MV;Urbon,JMG;Manzorro,AG;Martinez,E et al, A critical view on the current use of daptomycin in Spain: The daptomise study, J Infect Public Health, 2023;16(7):1115-1122, doi:10.1016/j.jiph.2023.05.008
Research highlights
PROJECTS
1 Granted competitive project
5 Ongoing competitive projects
1 Started clinical trial
1 Ongoing clinical trial
2 Ongoing non competitive projects
PUBLISHED WORKS
1 Clinical guideline
2 Theses
NETWORKS
AGAUR SGR
ENOTTA
Selected projects
- 19INT001. Antibiotic plasma level concentrations during continuous renal replacement therapy with a high absorptive membrane (oXiris®). BAXTER HEALTHCARE CORPORATION. Budget: 11.065,26€. 2019-2023. PI: Colom Codina, Helena.
- PUB23009. HUB – RECCaracterización de las dislipemias poligénicas: de la teoría a la práctica. Hospital Universitario de Bellvitge. Budget: 20.000€. 2023-2026. PI: Padró i Miquel, Ariadna.
- 21MAR009. Catalan interhospital network of genetic variants to improve genetic diagnosis in rare diaseases. Fundació La Marató de TV3. Budget: 26.625€. 2021-2024. PI: Padró i Miquel, Ariadna.
- 19PNJ030. CONTROLES DE CALIDAD DEL ESTUDIO “ESTUDIO DE EVALUACIÓN-VALIDACIÓN DE INMUNOSUPRESORES (EVEROLIMUS Y SIROLIMUS). 2019- . PI: Alía Ramos, Pedro.
- 2023-593-1. ESTUDIO OBSERVACIONAL PARA EVALUAR LA ADHERENCIA A TREMFYA® (GUSELKUMAB) EN LA PRÁCTICA CLÍNICA EN PACIENTES CON PSORIASIS MODERADA A GRAVE. Janssen-Cilag, S.A. Budget: 10.800€. 2023- . PI: Padullés Zamora, Núria.